Skip to content

Author

Francesco Fiorentino

We have 5 of 51 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

METTL3–METTL14 Heterodimer Assembly Enables Multivalent RNA Engagement and Is Tuned by Interface-Targeting Peptides

RNA N6-methyladenosine (m6A) deposition by the METTL3–METTL14 complex regulates RNA metabolism and thereby influences cell differentiation and stress responses. Dysregulated m6A deposition has been implicated in multiple cancers, where METTL3–METTL14 supports oncogenic programs. Yet the molecular basis of RNA recogniti...

Francesco Fiorentino, Bo-Yi Xiao, Bianca Cesaro et al. · 0 citations
Open access Nov 2026

Dual Histone Deacetylase/PD-1/PD-L1 Inhibitors Reprogram Tumor−Immune Interactions and Are Effective in Therapy-Resistant Melanoma

Epigenetic modulators and immune checkpoint inhibitors represent two major therapeutic avenues in oncology, yet resistance and recurrence limit their efficacy. To address this, we designed and synthesized a series of dual histone deacetylase (HDAC)/PD-1/PD-L1 inhibitors (compounds 1−6). Among them, compounds 4 (HDAC6...

Alessia Raucci, A. Fragale, I. Pacella et al. · 0 citations
Review Open access Oct 2026

What are the potentials of the different sirtuin proteins as therapeutic targets?

INTRODUCTION Sirtuins (SIRT1-7) are NAD+-dependent lysine deacylase and mono-ADP ribosyl transferase enzymes that integrate metabolic status with epigenetic regulation, genome maintenance, mitochondrial homeostasis, and adaptive stress responses. Their dysregulation is implicated in cancer, neurodegeneration, cardiomet...

Emanuele Fabbrizi, G. Hailu, Andrea Mancini et al. · 0 citations
Review Open access Aug 2026

Deubiquitinase-targeting chimeras (DUBTACs): a game-changing approach for targeted protein stabilization in drug discovery.

Targeted protein degradation (TPD) has transformed drug discovery by enabling event-driven elimination of pathogenic proteins, but many diseases arise from protein insufficiency and require restoration rather than removal. Deubiquitinase (DUB)-targeting chimeras (DUBTACs) offer a complementary proximity-pharmacology ap...

G. Hailu, Emanuele Fabbrizi, Andrea Mancini et al. · 0 citations
Review Open access Jul 2026

METTL1/WDR4 Complex: A Novel Epitranscriptomic Target at the Crossroads of RNA Methylation and Drug Discovery

Advances provide the first chemical foothold for therapeutic modulation of m7G pathways and underscore METTL1 as a promising yet complex target requiring careful biological stratification.

Emanuele Fabbrizi, Gebremedhin S. Hailu, Andrea Mancini et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.